Northpond Ventures, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Reported portfolio value by quarter (12 quarters reported)

$286M $21M

Q4 21 Q3 22 Q2 23 Q1 24 Q3 24

$286M in Q4 2021 → $43.7M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2024. Activity is the change in share count since the prior quarter's filing.

Holding	% of portfolio	Activity	Shares	Value
Kyverna Therapeutics Inc	36.5%	Unchanged	3,255,426	$15.9M
Vigil Neuroscience Inc	32.8%	Unchanged	4,214,498	$14.3M
Candel Therapeutics Inc	30.7%	Unchanged	1,935,215	$13.4M

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

quarter ended September 30, 2024 · filed November 14, 2024

Company	Action	Shares changed	Value of change	% of portfolio
Telesis Bio Inc	Exited	−546,897	−$2M	—

quarter ended June 30, 2024 · filed August 14, 2024

Company	Action	Shares changed	Value of change	% of portfolio
Telesis Bio Inc	Exited	−9,844,130	−$4.33M	—
Telesis Bio Inc	New	+546,897	+$2M	3.6%

quarter ended March 31, 2024 · filed May 15, 2024

Company	Action	Shares changed	Value of change	% of portfolio
Kyverna Therapeutics Inc	New	+3,255,426	+$80.9M	78.8%

quarter ended December 31, 2023 · filed February 14, 2024

No position changes this quarter.

quarter ended September 30, 2023 · filed November 14, 2023

Company	Action	Shares changed	Value of change	% of portfolio
P Phenomex Inc	Exited	−5,390,820	−$2.64M	—

quarter ended June 30, 2023 · filed August 14, 2023

Company	Action	Shares changed	Value of change	% of portfolio
DT Dice Therapeutics Inc	Exited	−3,292,871	−$94.3M	—

quarter ended March 31, 2023 · filed May 15, 2023

Company	Action	Shares changed	Value of change	% of portfolio
I Isoplexis Corp	Exited	−8,808,531	−$13.7M	—
P Phenomex Inc	New	+5,390,820	+$6.25M	3.6%

quarter ended December 31, 2022 · filed February 01, 2023

No position changes this quarter.

Comments